En

En

中文简体

中文繁体

  • Our Company

    Back

    Our Company

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China

    About Company

    Leadership

    Honor

    Brand Culture

    Member Companies

    Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.
  • Our Business

    Back

    Our Business

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.

    Pharmaceutical Manufacturing

    Vaccines

    Medical Devices

    Medical Diagnosis

    Healthcare Services

    Pharmaceutical Distribution And Retail

    Fosun Pharma is patient-centered and clinical needs-oriented. The company enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma has formed technological platforms for innovative small molecule drugs, antibody drugs, and cell therapy with a focus on key disease areas including oncology and immunomodulation, metabolism and digestive system, and central nervous system. Fosun Pharma also vigorously explores cutting-edge technologies, such as RNA, oncolytic viruses, gene therapy and PROTAC, to enhance its innovation capabilities.
  • R&D

    Back

    R&D

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

    Global R&D Center

    R&D Pipeline

    Innovation Platform

    Clinical Development

    R&D News

    Guided by innovation and internationalization, the company continuously enriches its innovative product pipeline through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products.
  • Sustainability

    Back

    Sustainability

    In pursuit of sustainable development of talents and products is the social responsibility concept of Fosun Pharma.

    Social Responsibility Strategy

    Special Fund For Fosun Pharma Health Care Initiative

    Social Welfare

    CSR News

    Relevant Policies

    ESG And Sustainability Report Download

    Fosun Pharma has incorporated sustainable development into the Group's overall development strategy, emphasizing long-term ESG governance capabilities, and established a three-level ESG governance structure supervised by the board of directors (the “Board”), implemented by the ESG Committee, and executed by the ESG Working Group. The ESG Committee of the Board is responsible for formulating and promoting the Group's ESG vision, goals, and strategies, and provides advice to the Board; the ESG Working Group is responsible for sorting out key ESG issues, formulating sustainable development quantitative targets, and tracking progress. The ESG Committee and the ESG Working Group are committed to integrating ESG concepts into corporate operations and enhancing the company's sustainability.
  • Investor Relations

    Back

    Investor Relations

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

    Announcements

    Corporate Governance

    Financial Report

    Investor Presentation Materials

    FAQS

    Investor Contact

    Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Group Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
  • News

    Back

    News

    Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China.

    Press Release

    Member Companies News

    Media Resources

    Media Contact

    Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group deep-rooted in China. Fosun Pharma directly operates businesses including pharmaceutical manufacturing, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.
  • Careers

    Back

    Careers

    Some top talent with strong entrepreneurship gathers here with us.

    Talent Concept

    Incentives

    Life At Fosun Pharma

    Join Us

    We are looking for people that recognize and practice our cultural values, and can learn fast to create continuous value; possess profound professional knowledge of the industry, a wide vision of different regions, and global-level expertise in a certain field. We will also be committed to cultivating international top talent with outstanding performance and great potential.
  • 2022-03-22

    The Corporate Social Responsibility Report of Fosun Pharma has been honored with the Five-star Report (Excellent) by the China Corporate Social Responsibility Report Rating Expert Committee for two consecutive years

    China Corporate Social Responsibility Report Rating Expert Committee

  • 2021-08-26

    Fosun Pharma has been honored with the China Company Award of Hong Kong Business Awards for 2021

    South China Morning Post

  • 2021-07-21

    Fosun Pharma ranked 6th in the 2020 Top 100 Chinese Chemical and Pharmaceutical Enterprises

    China Medical and Health Industry Symbiosis Conference

  • Rankings and Awards

    1. Ranked 4th in China's Top 100 Pharmaceutical Industries in 2021

      Ministry of Industry and Information Technology of the People's Republic of China

    2. Top 25 Global Pharma Companies by R&D Pipeline Size

      Informa Pharma Intelligence

    3. Ranked 6th in Top 100 Chinese Chemical and Medical Enterprises in 2021

      MENET.com.cn

    4. Top 100 of 2022 China's Enterprises in Science and Technology Innovation

      Southern Weekly

    5. Awarded 2022 Business Excellence Award of the 20th China Financial Billboard

      Hexun.com

    6. Awarded Golden Whistle Award for Top 10 China M&A Deals in 2021

      Morning Whistle Group

    7. Top 10 Health Care Brands in 2022

      Beijing Evening News

    8. Awarded the “Most Growing Listed Company in Biomedicine” Award in the 12th China Listed Companies Word-of-Mouth List in 2022

      Daily Business News

    9. "Golden Wisdom Award" – 2022 Outstanding Brand Award for China’s Listed Companies

      JRJ.com

  • Social Responsibility

    1. Ranked "A" in MSCI ESG Rating

      MSCI

    2. 2022 Technology Responsibility - Pioneer 30 Index List

      ESG Special Committee for Social Responsibility 100 Forum guided by China Academy of Social Sciences

    3. 2021 Corporate Social Responsibility Report selected as Five-star Report (Excellent)

      China Corporate Social Responsibility Report Rating Expert Committee

    4. Annual Enterprise Award in the People's Corporate Social Responsibility Award Selection

      People's Daily, People's Daily Online

    5. Top 20 ESG Competitiveness List of China's Listed Pharmaceutical Enterprises in 2022

      Healthcare Executive, Business Consulting

    6. Awarded 2022 Green Star for Excellence in ESG Performance

      Punctuation Research Institute of Finance and Economics, Investment Times

    7. Selected on 2022 Fortune China ESG Impact List

      Fortune

    8. Awarded the “Most Socially Responsible Listed Company” Award in the 12th Word-of-Mouth List for Chinese Listed Companies in 2022

      Daily Business News